Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

International study identifies new gene targets for hypertension treatment

12.09.2011
Results implicate pathways not previously associated with blood pressure as targets for new therapies

A new report from scientists at Massachusetts General Hospital (MGH) and their colleagues in centers around the world finds that common variants in 28 regions of DNA are associated with blood pressure in human patients. Of the identified regions, most were completely unsuspected, although some harbor genes suspected of influencing blood pressure based on animal studies.

In the study receiving advance online publication in Nature, members of the International Consortium for Blood Pressure Genome-Wide Association Studies (ICBP-GWAS) analyzed genetic data from over 275,000 individuals from around the world. They also identified for the first time the involvement of an important physiologic pathway in blood pressure control, potentially leading to a totally new class of hypertension drugs.

"Identifying these novel pathways expands our current understanding of the determinants of blood pressure and highlights potential targets for new drugs to treat and prevent cardiovascular complications," says Christopher Newton-Cheh, MD, MPH, of the MGH Center for Human Genetic Research and the Cardiovascular Research Center, co-chair of the ICBP-GWAS Steering Committee and a senior and corresponding author on the Nature paper.

It is well known that hypertension can run in families and that some rare genetic syndromes raise blood pressure, but identifying genes associated with the common form of hypertension has been challenging. To get a study sample large enough to detect variants with modest effects, ICBP-GWAS researchers conducted a meta-analysis of 30 genome-wide association studies that included measurements of participants' blood pressures. Analysis of 2.5 million DNA sequence variants in more than 69,000 individuals of European ancestry identified several chromosomal regions where genes influencing blood pressure appeared to be located. To confirm the results of the first-stage analysis, the researchers genotyped the strongest variants in more than 133,000 additional individuals of European descent. Combining the results identified 28 gene regions associated with both systolic and diastolic blood pressure, of which 16 were novel. A second paper from the consortium also receiving online publication today in Nature Genetics, identified six additional novel variants..

Some of the new variants were already known to cause other diseases. "We were quite astonished to see that two common variants known for decades to cause hemochromatosis – an iron overload condition that affects as many as 1 in 300 Americans – were also associated with higher blood pressure," says Newton-Cheh. "The hemochromatosis genes are part of a physiologic pathway that is also involved in pulmonary hypertension, but this finding opens our eyes to its potential involvement in systemic hypertension."

To test whether the blood pressure variants identified in Europeans were associated with blood pressure in other ethnicities, the consortium genotyped almost 74,000 individuals of either East Asian, South Asian or African ancestries. Genetic risk scores incorporating all identified variants were strongly associated with blood pressure levels in each of those groups and also with the risk of stroke and coronary heart disease. "Seeing that the blood pressure variants in aggregate lead to stroke and heart attack was perhaps not surprising, given the evidence that blood pressure treatment lowers these risks," said Newton-Cheh.

But the most important finding may be identification of a new pathway central to blood pressure regulation. Three of the 28 blood-pressure-associated regions include genes that are part of a pathway called the cyclic guanosine monophosphate (cGMP) system, which is involved in the relaxation of blood vessels and excretion of sodium by the kidneys, two fundamental mechanisms of hypertension treatment. Animal studies have suggested a role for this pathway in blood pressure control, and the current findings strongly support its relevance in human patients.

"We have previously shown that variants in natriuretic peptide genes, part of the cGMP system, influence blood pressure. We were therefore pleased but not surprised to see other genes that influence the cGMP system in this recent crop of discoveries," said Newton-Cheh, an assistant professor of Medicine at Harvard Medical School. "The greatest attention in blood pressure research has been focused on another pathway called the renin-angiotensin-aldosterone system (RAAS), which is targeted by several hypertension therapies. But only one common gene variant has been associated with genes in the RAAS pathway.

"Finding several independent associations that converge on cGMP points to its central importance in blood pressure control," he adds. "In fact, there are several drugs that target these systems in development to treat pulmonary hypertension and heart failure, but our findings suggest that they could have a much larger role in hypertension treatment in general. The next phase of our research will focus on finding additional genes and variants that influence blood pressure and on establishing how some of the cGMP-involved genes affect blood pressure in humans and respond to existing drugs and to those in development."

Additional MGH co-authors of the Nature report are Pankaj Arora, MD, Center for Human Genetic Research (CHGR); Sekar Kathiresan, MD, Cardiovascular Research Center and Center for Human Genetic Research; and David Altshuler, MD, PhD, Molecular Biology, Diabetes Unit and CHGR.

Co-corresponding authors of the paper are Aravinda Chakravarti, PhD of Johns Hopkins Medical School; Mark Caulfield, MBBS, MD, and Patricia Munroe, MSc, PhD, University of London; and Daniel Levy, MD of the National Heart Lung and Blood Institute.

The International Consortium for Blood Pressure Genome-Wide Association Studies includes 346 investigators from over 200 centers in 24 countries across the U.S., Europe, Asia and Australia. Support for the study came from over 100 governmental, charitable, and commercial organizations in the U.S., Europe, Asia and Australia, including the National Institutes of Health, the Doris Duke Charitable Foundation and the Burroughs Wellcome Fund.

Celebrating the 200th anniversary of its founding in 1811, Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School. MGH conducts the largest hospital-based research program in the United States, with an annual research budget of nearly $700 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.

Kristen Stanton | EurekAlert!
Further information:
http://www.massgeneral.org/

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: It’s All in the Mix: Jülich Researchers are Developing Fast-Charging Solid-State Batteries

There are currently great hopes for solid-state batteries. They contain no liquid parts that could leak or catch fire. For this reason, they do not require cooling and are considered to be much safer, more reliable, and longer lasting than traditional lithium-ion batteries. Jülich scientists have now introduced a new concept that allows currents up to ten times greater during charging and discharging than previously described in the literature. The improvement was achieved by a “clever” choice of materials with a focus on consistently good compatibility. All components were made from phosphate compounds, which are well matched both chemically and mechanically.

The low current is considered one of the biggest hurdles in the development of solid-state batteries. It is the reason why the batteries take a relatively long...

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Air pollution leads to cardiovascular diseases

21.08.2018 | Ecology, The Environment and Conservation

Researchers target protein that protects bacteria's DNA 'recipes'

21.08.2018 | Life Sciences

A paper battery powered by bacteria

21.08.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>